Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLOAGO: GnRH Agonist for Luteal Phase Support in IVF
NCT06150703Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2024
- Primary completion
- Sep 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin, nafarelin in infertility, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2024; status: recruiting.
02
Drugs
triptorelinnafarelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06150703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06150703.